Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction

被引:0
|
作者
Santiago, Luis E. [1 ,2 ]
Alvi, Ali Tariq [1 ,2 ]
Melnychuk, Veniamin [1 ,2 ]
Mesquita, Philip [1 ,2 ]
Aneja, Pallavi [1 ,2 ]
机构
[1] HCA Florida Northwest Hosp, Internal Med, Margate, FL 33324 USA
[2] HCA Florida Westside Hosp, Internal Med, Plantation, FL 33324 USA
关键词
ttr cardiac amyloidosis; cardiac amyloidosis with reduced ejection fraction; diastolic heart failure; cardiac amyloidosis; immunoglobulin light-chain amyloidosis; DIAGNOSIS;
D O I
10.7759/cureus.55271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic amyloidosis is caused by the extracellular deposition of misfolded proteins in various organs and usually leads to organ dysfunction. The two common subtypes include light -chain amyloidosis and transthyretin amyloidosis. Deposition of these proteins in the heart can lead to infiltrative and restrictive cardiomyopathy, commonly manifesting as heart failure with preserved ejection fraction. However, systolic heart failure with reduced ejection fraction is mainly seen in the advanced stages of the disease. Here, we present the case of a 53 -year -old female who presented with new -onset heart failure with reduced ejection fraction with no prior symptoms or diagnosis of amyloidosis and diastolic dysfunction.
引用
下载
收藏
页数:10
相关论文
共 50 条
  • [21] The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
    Gosling, Rebecca C.
    Al -Mohammad, Abdallah
    CARDIAC FAILURE REVIEW, 2022, 8
  • [22] The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement
    Dubrey, SW
    Cha, K
    Anderson, J
    Chamarthi, B
    Reisinger, J
    Skinner, M
    Falk, RH
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1998, 91 (02): : 141 - 157
  • [23] Light-chain cardiac amyloidosis: A multimodality approach
    Alexanderson-Rosas, Erick
    Escudero-Salamanca, Mara
    Garcia-Diaz, Jesus A.
    Alvarez-Santana, Ricardo
    Cano-Zarate, Roberto
    Mamani-Tito, Julio
    Carvajal-Juarez, Isabel
    Espinola-Zavaleta, Nilda
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (06) : 2432 - 2435
  • [24] Predictors of progression of light-chain cardiac amyloidosis
    Rameeva, A. S.
    Vedanova, K. V.
    Rameev, V. V.
    Safarova, A. F.
    Bobkova, I. N.
    Kozlovskaya, L. V.
    Moiseev, S. V.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1237 - 1237
  • [25] Light-chain cardiac amyloidosis: A multimodality approach
    Erick Alexanderson-Rosas
    Mara Escudero-Salamanca
    Jesus A. Garcia-Diaz
    Ricardo Alvarez-Santana
    Roberto Cano-Zarate
    Julio Mamani-Tito
    Isabel Carvajal-Juarez
    Nilda Espinola-Zavaleta
    Journal of Nuclear Cardiology, 2020, 27 : 2432 - 2435
  • [26] Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
    Palladini, Giovanni
    Milani, Paolo
    Malavasi, Fabio
    Merlini, Giampaolo
    CELLS, 2021, 10 (03) : 1 - 11
  • [28] Heart failure with reduced ejection fraction
    Bloom, Michelle W.
    Greenberg, Barry
    Jaarsma, Tiny
    Januzzi, James L.
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Trochu, Jean-Noel
    Butler, Javed
    NATURE REVIEWS DISEASE PRIMERS, 2017, 3
  • [29] Heart failure with reduced ejection fraction
    Michelle W. Bloom
    Barry Greenberg
    Tiny Jaarsma
    James L. Januzzi
    Carolyn S. P. Lam
    Aldo P. Maggioni
    Jean-Noël Trochu
    Javed Butler
    Nature Reviews Disease Primers, 3
  • [30] Light-chain (AL) amyloidosis: Diagnosis and treatment
    Sanchorawala, Vaishali
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (06): : 1331 - 1341